PLUS THERAPEUTICS, INC. — Director's Dealing 2013

Feb 4, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2013-01-31

Reporting Person: HEDRICK MARC H (Director, President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-01-31	Restricted Stock (Common Stock)	D	15477	—	Disposed	504611	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-01-31	Employee Stock Option	$2.74	A	183333	Acquired	2023-01-31	Common Stock (183333)	Direct
2013-01-31	Employee Stock Option	$5.00	A	91667	Acquired	2023-01-31	Common Stock (91667)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9600	Indirect
Common Stock	7500	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant to Purchase Common Stock	$2.62	2014-05-12	Common Stock (35000)	35000	Direct

Footnotes

F1: On January 31st, 2013 the Compensation Committee of the Board of Directors determined that 58% of the performance goals for the 2012 performance conditioned restricted stock grant were achieved, and that such percentage of shares granted will continue to time vest through January 10, 2014. The remaining portion of the 2012 performance grant shares (42%) are no longer qualified to continue vesting and have been cancelled. The disposition of these cancelled shares is reflected in Table I above.

F2: These securities are owned by M Hedrick & T Hedrick TTEE Dr. Marc Hamilton Hedrick & TRA U/A DTD 09/13/1999.

F3: The Employee Stock options vest 1/48th each month from date of grant.